搜索临床试验以:CYP2C19
总计1130个结果
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Sichuan Haisco Pharmaceutical Group Co., Ltd完全的
-
Oswaldo Cruz FoundationMinistry of Health, Brazil终止
-
Kirby InstituteChelsea and Westminster NHS Foundation Trust完全的
-
Sociedad Andaluza de Enfermedades InfecciosasConsejeria de Salud. Junta de Andalucia. Spain完全的
-
National Institute of Allergy and Infectious Diseases...University of Alabama at Birmingham完全的
-
Centers for Disease Control and PreventionUniversity of Alabama at Birmingham; Universidad del Valle, Guatemala完全的
-
National Center for Research Resources (NCRR)National Multiple Sclerosis Society完全的
-
Maastricht University Medical CenterZuyderland Medical Centre招聘中
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Jiangsu HengRui Medicine Co., Ltd.未知Healthy Subjects, Drug-drug Interaction, Pyrotinib中国
-
Peking Union Medical College HospitalNational Key Technologies R&D Program for the 13th Five-year Plan; National Key Technologies... 和其他合作者完全的
-
University of OuluOulu University Hospital完全的
-
Hoffmann-La Roche完全的
-
Nivalis Therapeutics, Inc.Davita Clinical Research完全的
-
Kirby InstituteImperial College London完全的
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)终止
-
Bamrasnaradura Infectious Diseases InstituteThai Red Cross AIDS Research Centre; Clinical Research Collaborative Network完全的Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine HypersensitivityTreatment Failure, HIV or AIDS | CD4 Cell Counts泰国
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
National Institute of Allergy and Infectious Diseases...Pfizer完全的
-
National Institute of Allergy and Infectious Diseases...Washington University School of Medicine完全的
-
National Hospital for Tropical Diseases, Hanoi,...Centers for Disease Control and Prevention未知